Controlling Health Care Costs Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier? Issue Briefs / Oct 05, 2017
Controlling Health Care Costs The Case for Drug-Pricing Reform — The Cost of Inaction blog / May 26, 2021
Controlling Health Care Costs External Reference Pricing: The Drug-Pricing Reform America Needs? Issue Briefs / May 27, 2021
Controlling Health Care Costs How Federal Drug-Pricing Proposals Could Affect Medicaid blog / Aug 19, 2021
Controlling Health Care Costs Reducing Medicaid Prescription Drug Costs While Maintaining Beneficiary Access: MACPAC Recommendations for Accelerated-Approval Drugs blog / Aug 18, 2021
Controlling Health Care Costs Catastrophic Coverage in the Medicare Part D Drug Benefit: Which Beneficiaries Need It and How Much Are They Spending? Issue Briefs / Sep 17, 2020
Controlling Health Care Costs The Cost of Speed: FDA Regulatory Flexibilities During the Coronavirus Pandemic Blog / Aug 20, 2020
Controlling Health Care Costs Drug Pricing and Pandemic Preparedness in the 2022 FDA User Fee Reauthorization Process Blog / Jul 23, 2020
Improving Health Care Quality COVID-19 Highlights Problems with Our Generic Supply Chain Blog / May 07, 2020
Controlling Health Care Costs The Elijah E. Cummings Lower Drug Costs Now Act: How It Would Work, How It Would Affect Prices, and What the Challenges Are Issue Briefs / Apr 09, 2020
Controlling Health Care Costs Will Medicare Prescription Drug Reform Legislation Make Insulin More Affordable? Journal Article / Apr 02, 2020
Improving Health Care Quality Comparative Effectiveness Research, 10 Years After the ACA: Where Do We Go from Here? Blog / Mar 12, 2020
Achieving Universal Coverage The Forecast for Legislative and Regulatory Activity on Health Care in 2020 Blog / Feb 06, 2020
Controlling Health Care Costs What’s Missing from the Debate About Controlling Drug Costs? Podcast / Jan 31, 2020
Controlling Health Care Costs Gazing Back and Looking Forward: Drug-Pricing Reform in 2019 and 2020 Blog / Jan 24, 2020
Controlling Health Care Costs Drug Price Moderation in Germany: Lessons for U.S. Reform Efforts Issue Briefs / Jan 23, 2020